Literature DB >> 4310054

The delayed neurotoxic effect of some organophosphorus compounds. Identification of the phosphorylation site as an esterase.

M K Johnson.   

Abstract

1. Organophosphorus compounds that produce a delayed neurotoxic effect in hens phosphorylate a specific site in the brain soon after administration. 2. Phosphorylation of the specific site by di-isopropyl [(32)P]phosphorofluoridate in vitro is blocked by the prior addition of phenyl phenylacetate. 3. A small proportion of the total activity of hen brain hydrolysing phenyl phenylacetate in vitro was shown to be due to an enzyme different from two others previously described. 4. This enzyme is only slightly inhibited in vitro by concentrations of tetraethyl pyrophosphate and paraoxon (diethyl 4-nitrophenyl phosphate) up to 64mum and is completely inhibited by 6mum-di-isopropyl phosphorofluoridate and 128mum-mipafox. 5. It is also inhibited in vivo by effective doses of neurotoxic organophosphorus compounds but not by high doses of non-neurotoxic analogues. 6. It is deduced that the active site of this enzyme is the phosphorylation site associated with the genesis of delayed neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4310054      PMCID: PMC1184957          DOI: 10.1042/bj1140711

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

1.  Carbamylation of acetvlcholinesterase.

Authors:  I B WILSON; M A HATCH; S GINSBURG
Journal:  J Biol Chem       Date:  1960-08       Impact factor: 5.157

2.  Tricresyl phosphates and cholinesterase.

Authors:  W N ALDRIDGE
Journal:  Biochem J       Date:  1954-02       Impact factor: 3.857

3.  Cholinesterase levels in the nervous system in tri-ortho-cresyl phosphate poisoning.

Authors:  C J EARL; R H S THOMPSON
Journal:  Br J Pharmacol Chemother       Date:  1952-12

4.  A biochemical and morphologic study of myelination and demyelination. III. Effect of an organo-phosphorus compound (Mipafox) on the biosynthesis of lipid by nervous tissue of rats and hens.

Authors:  G MAJNO; M L KARNOVSKY
Journal:  J Neurochem       Date:  1961-10       Impact factor: 5.372

5.  The experimental neuropathy in rats caused by p-bromophenylacetylurea.

Authors:  J B Cavanagh; F C Chen; M H Kyu; A Ridley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-10       Impact factor: 10.154

6.  Protection by some carbamates against the delayed neurotoxic effects of di-isopropyl phosphorofluoridate.

Authors:  M K Johnson; R Lauwerys
Journal:  Nature       Date:  1969-06-14       Impact factor: 49.962

7.  Studies on esterases in the chicken central nervous system.

Authors:  E Poulsen; W N Aldridge
Journal:  Biochem J       Date:  1964-01       Impact factor: 3.857

8.  A method for the characterization of two similar B-esterases present in the chicken central nervous system.

Authors:  W N Aldridge
Journal:  Biochem J       Date:  1964-12       Impact factor: 3.857

9.  Esterases and neurotoxicity of some organophosphorus compounds.

Authors:  W N Aldridge; J M Barnes
Journal:  Biochem Pharmacol       Date:  1966-05       Impact factor: 5.858

10.  Effect of pH on inhibition and spontaneous reactivation of acetylcholinesterase treated with esters of phosphorus acids and of carbamic acids.

Authors:  E Reiner; W N Aldridge
Journal:  Biochem J       Date:  1967-10       Impact factor: 3.857

View more
  51 in total

1.  Neurotoxicity of acrylamide and its analogues and effects of these analogues and other agents on acrylamide neuropathy.

Authors:  P M Edwards
Journal:  Br J Ind Med       Date:  1975-02

Review 2.  Protein adducts as biomarkers of exposure to organophosphorus compounds.

Authors:  Judit Marsillach; Lucio G Costa; Clement E Furlong
Journal:  Toxicology       Date:  2012-12-20       Impact factor: 4.221

3.  Neuropathy target esterase catalyzes osmoprotective renal synthesis of glycerophosphocholine in response to high NaCl.

Authors:  Morgan Gallazzini; Joan D Ferraris; Margarita Kunin; Ryan G Morris; Maurice B Burg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-02       Impact factor: 11.205

4.  Constructs of human neuropathy target esterase catalytic domain containing mutations related to motor neuron disease have altered enzymatic properties.

Authors:  Nichole D Hein; Jeanne A Stuckey; Shirley R Rainier; John K Fink; Rudy J Richardson
Journal:  Toxicol Lett       Date:  2010-04-09       Impact factor: 4.372

5.  Neuropathy target esterase and a homologous Drosophila neurodegeneration-associated mutant protein contain a novel domain conserved from bacteria to man.

Authors:  M J Lush; Y Li; D J Read; A C Willis; P Glynn
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

Review 6.  Prophylaxis and the mechanism for the initiation of organophosphorous compound-induced delayed neurotoxicity.

Authors:  C D Carrington
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

7.  Clinical and toxicological investigations of a case of delayed neuropathy in man after acute poisoning by an organophosphorus pesticide.

Authors:  R Hierons; M K Johnson
Journal:  Arch Toxicol       Date:  1978-08-09       Impact factor: 5.153

8.  Neurotoxic esterase. Identification of two isoenzymes in hen brain.

Authors:  J M Chemnitius; K H Haselmeyer; R Zech
Journal:  Arch Toxicol       Date:  1983-07       Impact factor: 5.153

9.  Intramolecular group transfer is a characteristic of neurotoxic esterase and is independent of the tissue source of the enzyme. A comparison of the aging behaviour of di-isopropyl phosphorofluoridate-labelled proteins in brain, spinal cord, liver, kidney and spleen from hen and in human placenta.

Authors:  D G Williams
Journal:  Biochem J       Date:  1983-03-01       Impact factor: 3.857

Review 10.  Organophosphorus esters causing delayed neurotoxic effects: mechanism of action and structure activity studies.

Authors:  M K Johnson
Journal:  Arch Toxicol       Date:  1975-12-18       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.